This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: F01.1 | Special Copayment Reduction: V810 (severe intractable disease, 5 years) |
| B. Synonyms | Predominantly cortical dementia, cortical vascular dementia, multi-infarct dementia (MID) |
| C. Adult onset | Yes — gradual, stepwise onset after repeated ischemic cerebral infarcts; middle-aged to older adults. |
| 1. History | Hachinski et al. named "multi-infarct dementia" in 1974; the concept of dementia due to the accumulation of multiple cortical ischemic infarcts was established. |
| 2. Causes | Repeated cortical/subcortical cerebral infarcts; cardioembolism (atrial fibrillation, etc.); large-vessel atherosclerosis; hypertension. |
| 3. Genetics | Genes related to vascular risk factors (APOE ε4, Factor V Leiden, MTHFR); CADASIL (NOTCH3). |
| 4. General epidemiology | A major subtype of vascular dementia; about 10-15% of all dementia; 4-5-fold risk in patients with atrial fibrillation. |
| 5. Pathophysiology | Accumulation of repeated cortical infarcts → network dysfunction → stepwise cognitive decline; ischemia-reactive inflammation → additional neural damage. |
| 6. Symptoms | Stepwise cognitive decline; association with stroke episodes; focal neurological deficits; emotional changes. |
| 7. Signs | Hemiparesis, dysarthria, language disorder; multiple cortical/subcortical infarcts on MRI; Hachinski score of 7 or higher. |
| 8. Screening | Cognitive follow-up of patients with recurrent TIA/stroke; MoCA; long-term monitoring for atrial fibrillation. |
| 9. Diagnosis | NINDS-AIREN/VasCog criteria; MRI confirmation of multiple infarcts; temporal association. |
| 10. Treatment | Recurrence prevention (antithrombotics, blood pressure, glucose, and lipid control); anticoagulation for atrial fibrillation; cognitive rehabilitation. |
| 11. Prognosis | Can stabilize if recurrent stroke is prevented; further decline on recurrence; higher short-term mortality than Alzheimer disease. |
| 12. Prevention | Early treatment of atrial fibrillation; blood pressure and glucose control; antithrombotics; lifestyle management. |
| 13. References | Hachinski VC et al. Arch Neurol 1974 and 9 other references |
Multi-infarct dementia (MID) is a concept first named in a paper published in Archives of Neurology in 1974 by Hachinski, Lassen, and Marshall. They distinguished dementia due to reduced cerebral blood flow from dementia due to multiple cortical infarcts, and defined the latter as "multi-infarct dementia." The paper emphasized that the main mechanism of vascular dementia is repeated thromboembolic infarction rather than chronic ischemia.
The Hachinski Ischemic Score (HIS), published in 1975, is a tool for clinically differentiating vascular dementia from Alzheimer dementia, scoring 13 items such as abrupt onset, stepwise progression, nocturnal confusion, emotional changes, and history of hypertension. A score of 7 or higher suggests vascular dementia and 4 or lower suggests Alzheimer dementia. It was widely used in clinical research before brain MRI became universal and is still used as an auxiliary tool.
Since the 1990s, advances in brain MRI have made it possible to precisely identify the location and pattern of multiple infarcts, and pure MID (multiple cortical infarcts) and subcortical small vessel disease (Binswanger disease) have become clinically distinguishable. In ICD-10, F01.1 represents multi-infarct dementia centered on cortical infarcts and is distinguished from subcortical vascular dementia (F01.2). Recent vascular dementia research focuses on mixed pathology and integrated risk factor management beyond simple classification.
Multi-infarct dementia is a disease in which repeated ischemic infarcts accumulate in the cerebral cortex and cortical-subcortical connections, causing stepwise decline in cognitive function.
Atrial fibrillation is one of the most important causes of multi-infarct dementia. When thrombi form in the atria and repeatedly send emboli to the cerebral vessels, cortical infarcts accumulate. Valvular heart disease (especially mitral stenosis, prosthetic valves), mural thrombus after myocardial infarction, and infective endocarditis are also causes of cardioembolism.
Microemboli (artery-to-artery embolism) repeatedly arise from atherosclerotic plaques of the carotid and vertebrobasilar arteries, accumulating cortical infarcts. When carotid stenosis is 70% or more, the risk of ischemic stroke increases markedly.
Small vessel lesions caused by chronic hypertension (lipohyalinosis, microatheroma) can cause cortical and subcortical lacunar infarcts and contribute to MID. However, pure lacunar infarcts are more often classified as F01.2 (subcortical vascular dementia).
The genetic background of multi-infarct dementia is mainly explained by genes related to vascular risk factors and susceptibility to thrombus formation. APOE ε4 increases the risk of vascular dementia through atherosclerosis and amyloid angiopathy. Factor V Leiden (FVL, G1691A) and the prothrombin G20210A variant increase susceptibility to thrombus formation and can raise the risk of stroke and MID. The MTHFR C677T polymorphism raises homocysteine levels, increasing vascular endothelial dysfunction and stroke risk. CADASIL (NOTCH3 mutation) causes recurrent lacunar infarcts and subcortical vascular dementia, and in some cases is accompanied by cortical infarcts and may show an MID pattern.
Vascular dementia accounts for about 15-20% of all dementia, and multi-infarct dementia is an important subtype of vascular dementia. MID has traditionally been known to account for a higher proportion in Asia (China, Japan, Korea) than in the West, but recent studies consider that this difference is partly due to differences in diagnostic criteria and MRI use.
Atrial fibrillation increases the risk of vascular dementia 4-5-fold, and stroke prevention through anticoagulation also contributes to the prevention of vascular dementia. The annual incidence of vascular dementia in the population aged 65 and older is about 5-12 per 1,000, increasing exponentially with age.
In multi-infarct dementia, cognitive decline is explained by two mechanisms: cumulative infarct burden and network disconnection. Individual infarcts cause focal neural damage, and as these accumulate, key components of the large-scale networks supporting cognitive function (the default mode network, executive function network, language network, etc.) are damaged, leading to multi-domain cognitive decline.
After ischemic infarction, a local neuroinflammatory response is activated. Reactive changes of microglia and astrocytes, cytokine release, and blood-brain barrier damage cause additional neural damage in the penumbra around the infarct. In addition, remote neurodegeneration (diaschisis) at sites distant from the infarct further impairs the function of connected brain regions. This process repeats with each recurrent infarct, so dementia progresses in a stepwise manner.
The clinical features of multi-infarct dementia are stepwise cognitive decline and temporal association with stroke episodes. With each stroke episode, cognitive function declines abruptly and then partially recovers, but overall shows a stepwise declining trend. Depending on the site of the infarct, which of memory impairment, aphasia, apraxia, visuospatial processing abnormality, or executive function decline comes to the fore differs.
Focal neurological deficits such as hemiparesis, dysarthria, and dysphagia accompanying cognitive impairment are characteristic. Emotional changes (emotional incontinence, depression, apathy, irritability) and sleep disturbance are common. In the late course, gait disturbance, urinary incontinence, and reduced swallowing function appear.
On physical examination, focal neurological deficits such as hemiparesis or unilateral weakness, hyperreflexia, Babinski sign, dysarthria, and facial palsy are observed. Gait may show small steps, shuffling, or an unstable posture (festinating gait, short-stepped gait). On brain MRI, multiple cortical and subcortical infarct lesions (FLAIR hyperintensity) are characteristic, and infarct size and location vary. Bilateral infarcts are more strongly associated with cognitive decline than unilateral infarcts.
A Hachinski score (HIS) of ≥7, abrupt onset, stepwise progression, history of hypertension, focal neurological signs, and emotional incontinence suggest multi-infarct dementia.
In patients with recurrent TIA or stroke, cognitive function is assessed 3-6 months after the acute stroke phase using standardized methods (MoCA, MMSE, CDR). In the high-risk group for atrial fibrillation (age 65 or older, heart disease), asymptomatic atrial fibrillation is detected early by ECG screening or long-term wearable ECG monitoring. Atherosclerotic plaque and degree of stenosis are assessed by carotid ultrasound, and the indication for antiplatelet or anticoagulant therapy is evaluated in the high-risk group.
The diagnosis of multi-infarct dementia consists of three elements: ① meeting dementia criteria (multi-domain cognitive decline + decline in daily functioning), ② multiple cortical/subcortical infarct lesions on brain MRI, and ③ history of recurrent stroke episodes and temporal association with dementia. The NINDS-AIREN or VasCog 2014 criteria are applied. Amyloid PET or cerebrospinal fluid/plasma biomarkers are considered for differentiation from Alzheimer pathology. ECG, Holter monitoring, echocardiography, carotid ultrasound, and cerebral angiography are needed to identify cardiogenic causes.
Treatment of multi-infarct dementia focuses on preventing recurrence. It includes oral anticoagulants in atrial fibrillation (NOACs preferred), antiplatelet agents in non-cardioembolic ischemic stroke (aspirin, clopidogrel, cilostazol), blood pressure control (target SBP <130 mmHg), diabetes control, and statin therapy. Carotid endarterectomy (CEA) or carotid artery stenting (CAS) is considered for carotid stenosis of 70% or more. Cognitive rehabilitation (occupational therapy, memory training, speech-language therapy), management of depression and behavioral symptoms, and family education and support are needed.
In multi-infarct dementia, if stroke recurrence is successfully prevented, cognitive function may stabilize or partly improve. However, if recurrent stroke occurs, further cognitive decline appears in a stepwise manner. The risk of cardiovascular death is higher than in Alzheimer dementia, so short-term (1-3 year) mortality is higher. Managing vascular risk factors to prevent stroke recurrence is key to both slowing dementia progression and improving survival.
Early detection and anticoagulation of atrial fibrillation is the most important prevention strategy. Treating hypertension (target blood pressure <130/80 mmHg), controlling diabetes (HbA1c <7%), treating hyperlipidemia (LDL reduction), smoking cessation, exercise, maintaining an appropriate weight, and limiting alcohol reduce vascular risk factors and prevent MID. Education on recognizing stroke warning symptoms (TIA: transient hemiparesis, language disorder, visual field abnormality) and immediate use of medical care are important.